Paper
Paper
A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer
Gelber RD, Goldhirsch A, Cole BF, Wieand HS, Schroeder G, Krook JE. A quality adjusted time without symptoms or toxicity (Q-TWIST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer. J National Cancer Institute. 88(15): 1039-45, 1996.
Paper
Budesonide prolongs time to relapse in ileal and ileocaecal Crohn’s disease. A placebo controlled one year study
Lofberg R, Rutgeerts P, Malchow H et al. Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study. Gut. 1996;39:82-86.
Paper
Budesonide prolongs time to relapse in ileal and ileocaecal Crohn’s disease. A placebo controlled one year study
Lofberg R, Rutgeerts P, Malchow H et al. Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study. Gut. 1996;39:82-86.
Paper
Budesonide prolongs time to relapse in ileal and ileocaecal Crohn’s disease
Lofberg R, Rutgeerts P, Malchow H et al. Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study. Gut. 1996;39:82-86.
Paper
Immune response and protection of rats and mice from ricin aerosol exposure after vaccination with deglycosylated ricin A chain (Abstract)
Hewetson JF, A.A., Teters DR, Kotes JM, Washington E, Tamariello R, et al., Immune response and protection of rats and mice from ricin aerosol exposure after vaccination with deglycosylated ricin A chain (Abstract). Fundam Appl Toxicol, 1996. 30(Suppl.): p. 59.
Paper
Olsalazine is contraindicated during pelvic radiation therapy: Results of a double-blind, randomized clinical trial
Martenson JA Jr, Hyland G, Moertel CG, et al. Olsalazine is contraindicated during pelvic radiation therapy: Results of a double-blind, randomized clinical trial. Int J Radiat Oncol Biol Phys. 35(2): 299-303, 1996.
Paper
Intracellular survival of Burkholderia pseudomallei
Jones AL, Beveridge TJ, Woods DE. 1996. Intracellular survival of Burkholderia pseudomallei. Infect Immun 64: 782-90
Paper
Oral beclomethasone dipropionate for treatment of human intestinal graft-versus-host disease
Baehr P, Levine D, Bouvier M, Hockenbery D, Gooley T, Stern J, Martin P, and McDonald G. 1995. Oral beclomethasone dipropionate for treatment of human intestinal graft-versus-host disease. Transplantation 60:1231-8.
Paper
Review of the toxicology of beclomethasone dipropionate
Libretto, SE. Review of the toxicology of beclomethasone dipropionate. Archives of toxicology. 1995;69(8):509.
Paper
Bacterial toxins and virulence factors in disease
Holmes RK, J.M., Connell TD, Bacterial toxins and virulence factors in disease. Cholera toxin and related enterotoxins of gram-negative bacteria, ed. V.M. Moss BIJ, Tu AT. 1995, New York: Marcel Dekker, Inc.